ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Fox Retirement Marks End of Era for NCI Construction Program

October 6, 1989

ACS Goal To Raise Percentage Of Women Who Get Mammograms

July 31, 1992

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

June 29, 2012

Commission Urges Bypass Funding for Breast Cancer

November 5, 1993

Treatment research Reports Summarized; New MTX Rescues

May 6, 1977

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013